Executive Panel - Operationalizing AI in Discovery Biology: From Target Hypothesis to Translational Decision-Making

Oct 28, 2026
Discovery Biology

Examine how leading organizations are shifting to AI-first target identification and embedding multimodal models into core discovery workflows. Assess how causal systems biology and integrated data platforms are strengthening target validation and enabling more confident translational decision-making. Define the measurable impact AI is delivering from hypothesis through validation - improving speed, decision quality and probability of technical success.

Speakers
Richard Bonneau
Richard Bonneau, VP and Global Head,AI for Drug Discovery - Roche
Morten Sogaard
Morten Sogaard, Senior Vice President, Head of Astellas Innovation Lab - Astellas Pharma